The Impact of Medical TV Drama in Improving Literacy on Neurocysticercosis (NCT07208656) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
The Impact of Medical TV Drama in Improving Literacy on Neurocysticercosis
60 participantsStarted 2025-12-15
Plain-language summary
This randomized controlled trial evaluates whether exposure to a medical television drama improves knowledge of neurocysticercosis (NCC) among young adults. Sixty participants aged 18-35 will be randomly assigned to either an intervention group, which will watch a medically relevant TV episode (House M.D., Season 1, Episode 1), or a control group with no media exposure. Both groups will complete pre- and post-test questionnaires assessing knowledge of NCC. The primary outcome is change in NCC-related knowledge. Secondary outcomes include motivation to seek further health information and perceived credibility of the media source
Who can participate
Age range
18 Years – 35 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Aged 18 to 35 years
* Proficient in English (reading and comprehension)
* Has access to a stable internet connection
* Possesses a screen-enabled device (e.g., smartphone, tablet, or computer)
* Has access to the Netflix streaming platform
Exclusion Criteria:
* Has formal education in medical or health sciences
* Has a prior diagnosis of neurocysticercosis (NCC)
* Has previously participated in any NCC-related health literacy or awareness program
* Lacks access to the Netflix movie platform
* Below 18 years or above 35 years of age
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Neurocysticercosis (NCC) Knowledge Score
Timeframe: Baseline and immediately post-intervention (within 1 hour)
Trial details
NCT IDNCT07208656
SponsorCephas Health Research Initiative Inc, Ibadan, Nigeria